Sorafinib in combination with intensive chemotherapy for previously untreated adult FLT3-ITD positive AML: A phase 2 randomised double-blind placebo controlled multi-centre study (ALLG AMLM16)

Name: Sorafinib in combination with intensive chemotherapy for previously untreated adult FLT3-ITD positive AML: A phase 2 randomised double-blind placebo controlled multi-centre study (ALLG AMLM16)
Creator: Australasian Leukaemia and Lymphoma Group (ALLG)
Published: 2023-06-08T02:28:05+08:00